Reumatología
Servicio
Monash University
Melbourne, AustraliaPublicaciones en colaboración con investigadores/as de Monash University (13)
2024
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Seminars in Arthritis and Rheumatism, Vol. 65
2023
-
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 837-847
2021
-
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 3, pp. 593-600
2020
-
Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
ACR Open Rheumatology, Vol. 2, Núm. 8, pp. 459-470
2015
-
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis
Journal of Rheumatology, Vol. 42, Núm. 3, pp. 479-488
2014
-
Dietary supplements for chronic gout
Cochrane Database of Systematic Reviews, Vol. 2014, Núm. 10
-
Interleukin-1 inhibitors for acute gout
Cochrane Database of Systematic Reviews, Vol. 2014, Núm. 9
-
Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
Annals of the Rheumatic Diseases, Vol. 73, Núm. 2, pp. 328-335
-
The efficacy and safety of treatments for acute gout: Results from a series of systematic literature reviews including cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors
Journal of Rheumatology, Vol. 41, Núm. SUPPL. 92, pp. 15-25
-
The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study
Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1316-1322
-
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Annals of the Rheumatic Diseases, Vol. 73, Núm. 6, pp. 1020-1026
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196